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We report a case of a 16-year-old female who presented with bleeding diathesis. Peripheral blood ﬁlm
examination was consistent with microangiopathic hemolytic anemia with 7% fragmented red blood
cells. The ADAMTS13 level was 40 ng/ml (reference range: 630e850 ng/ml). She responded to plasma
exchange therapy and methylprednisolone and was discharged in a stable condition.
© 2019 Publishing services provided by Elsevier B.V. on behalf of King Faisal Specialist Hospital &
Research Centre (General Organization), Saudi Arabia. This is an open access article under the CC BY-NCND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Congenital thrombotic thrombocytopenic purpura (TTP), which
is also called as Upshaw-Schulman Syndrome, is a rare syndrome
caused by inherited deﬁciency of the metalloprotease ADAMTS13
(A Disintegrin and Metalloprotease with Thrombospondin-1elike
domains) [1]. Unlike the more common acquired form of TTP, which
is characterized by an acquired inhibitor of ADAMTS13, congenital
TTP shows deﬁciency of ADAMTS13,2 without an inhibitor [3]. It is
an autosomal recessive condition caused by several genetic mutations on chromosome 9q34. The function of ADAMTS13 is that it
cleaves a speciﬁc peptide bond in the von Willebrand factor (VWF)
subunit [2,3].
As ADAMTS 13 cleaves large multimers of von Willebrand factor,
its absence causes persistence of large multimers that are
uncleaved, thereby causing “spontaneous” platelet adhesion and
aggregation leading to thrombocytopenia [4,5].
Clinically, patients complain of fever, nausea, and vomiting
while the disease progresses; it may involve vital organs like
the brain and kidney and cause neurological deﬁcits and renal
failure [6].

* Corresponding author. Department of Pathology and Laboratory Medicine/
Oncology, Aga Khan University, stadium road, 74800, P O Box 3500, Karachi,
Pakistan.
E-mail address: natasha.ali@aku.edu (N. Ali).
Peer review under responsibility of King Faisal Specialist Hospital & Research
Centre (General Organization), Saudi Arabia.

Hematological examination reveals signs of hemolysis, which
include pallor, purpura, and jaundice, while laboratory ﬁndings
show thrombocytopenia, unconjugated hyperbilirubinemia,
increased LDH levels, and low haptoglobulin levels [7].
Peripheral blood smears are usually diagnostic, showing signs of
intravascular hemolysis like fragmented erythrocytes (schistocytes), nucleated red blood cells, and polychromatic red cells [4].
Here, we present a case of a 16-year-old girl with congenital TTP
who initially presented with a misdiagnosis of ITP. The purpose of
this case report is to spread awareness among clinicians regarding
this rare subtype of TTP, which can be treated promptly and
effectively and can also be fatal if left untreated. The case report also
emphasizes on the importance of peripheral blood ﬁlm, as fragmented red blood cells are pathognomonic for this condition.

2. Case report
A-16-year-old girl presented in the emergency department of
Aga Khan University, Karachi, with complaints of epistaxis,
menorrhagia, fever, and vomiting for one month. General physical
examination revealed pallor and jaundice with no visceromegaly.
The patient had history of repeated hospital admissions with low
platelet counts along with a low hemoglobin level, for which she
received multiple red cell units and platelet concentrates. Her bone
marrow examination was performed three years ago, which was
reported as peripheral destruction, and she was diagnosed as a case
of immune-mediated thrombocytopenic purpura (ITP). Her parents
had a consanguineous marriage, and she had ﬁve siblings who were
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healthy. Two months ago, she had undergone splenectomy at her
hometown for ITP.
At the time of admission in our hospital, the hemoglobin (Hb)
level was 6.2 g/dL, white blood cell (WBC) count was 5.6  109/L,
and platelet count was 9  109/L. Coagulation proﬁle showed prothrombin time of 10.9 seconds and activated partial thromboplastin
time of 22.2 seconds. Peripheral smear revealed 7% fragmented red
blood cells (FRBC) and nucleated red cells along with polychromatic
red cells (Figs. 1 and 2). Other investigations included a bilirubin
level of 4.5 mg/dl with indirect component of 2.9 mg/dL, serum
creatinine of 0.7 mg/dl, and LDH of 1401 I.U./L (normal ¼ 208e378
I.U./L). Direct Coomb's test result was negative.
Because of a history of fever, samples were sent for blood culture, which revealed no growth. Chest X-ray along with ultrasound
of the abdomen and pelvis was performed, which were unremarkable. She was diagnosed as a suspected case of microangiopathic hemolytic anemia (MAHA) on the basis of history,
physical examination ﬁndings, and peripheral smear examination.
Subsequently, serum ADAMTS 13 levels were extremely low, i.e., 40
ng/ml (reference 630e850 ng/ml). Depending on the ADAMTS13
levels, she was diagnosed with Upshaw Schulman syndrome
(congenital thrombotic thrombocytopenic purpura).
She underwent treatment with plasma exchange (a total of ﬁve
sessions) and immunosuppression in the form of methyl prednisolone (1G x once daily for three days followed by prednisolone 1
mg/kg twice daily). Menorrhagia was treated with oral norethisterone 5 mg thrice a day.
She responded to the above-mentioned treatment, and after ﬁve
sessions of plasma exchange, her Hb improved to 10.6 g/dL, with
the absence of FRBCs on peripheral blood ﬁlm. Her platelet count
increased to 221  109 cells/L. All other symptoms of bleeding
diathesis resolved, and LDH reduced to 683 I.U./L.
She was discharged in a stable condition and was referred to a
hematologist in her hometown, as it was not easy for the patient to
visit hematology clinics in Karachi.
3. Discussion
The purpose of this case report is to increase knowledge and
awareness among clinicians regarding this rare syndrome, which
can easily be treated if properly diagnosed, while its misdiagnosis
may lead to fatal consequence. In neonates and children, clinicians
can suspect congenital TTP with jaundice, hemolytic anemia, and
thrombocytopenia.

Fig. 1. Peripheral blood ﬁlm showing microangiopathic hemolytic anemia (40X).
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Fig. 2. Peripheral blood ﬁlm showing microangiopathic hemolytic anemia (40X).

This rare syndrome was ﬁrst diagnosed in 1960 by Schulman, in
an eight-year-old girl who experienced repeated episodes of
thrombocytopenia, which improved with plasma infusions [8]. In
1978, Upshaw described a similar case of a 29-year old with
recurrent episodes of thrombocytopenia associated with microangiopathic hemolytic anemia (MAHA), which also responded to
plasma infusions. He documented numerous episodes of MAHA in
his patient, and majority of these symptoms were precipitated by
acute infections or factors that culminated in stress, e.g., pregnancy
or surgery [9].
TTP classically consists of pentad of fever, microangiopathic
hemolytic anemia, thrombocytopenia, and variable renal and
neurologic dysfunction present on 20e30% of patients, while the
majority lack this classical presentation [6,7].
TTP is less commonly seen in children while usually seen in
women in their third or fourth decades of life [10]. There are two
forms of TTP: acquired and congenital.
It is essential to distinguish between congenital and acquired
forms of TTP. In female patients, it is important to discuss the implications of pregnancy, which can precipitate an episode of
microangiopathic hemolytic anemia (MAHA) [10,11]. For congenital
TTP, it is important to screen asymptomatic family members, as the
disease may precipitate in those individuals during times of stress
[11,12].
The treatment depends on restoring the ADAMST13 function
and removing/restoring the highly active von Willebrand proteins
by plasma exchange or fresh frozen plasma infusions [13]. Once
these patients achieve remission, the treatment is then subject to
the phenotype of individual patient. In few patients, the practice is
to transfuse plasma every 3e4 weeks to replace the deﬁcient
ADAMTS13 protein, while others will require plasma infusions if
there are any stimulating factors of TTP present, e.g., sepsis, pregnancy, etc. [14].
Scully et al. [15] recently reported a phase 1 study on human
subjects with congenital TTP who were treated with recombinant
ADAMTS 13. The study showed safe tolerability and no immunological reactions. This product is a potential treatment option in
patients with congenital TTP, which decreases the risk of
transfusion-transmitted infections associated with plasma
infusion.
Our patient was misdiagnosed as ITP previously and underwent
unnecessary splenectomy. The surgery could have been avoided if
peripheral blood ﬁlm examination was performed for FRBCs. At our
center, she responded well to the above-mentioned treatment. To
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prevent further episodes, she was started on prophylactic plasma
infusions (10e15 ml/kg) at four-weekly intervals for six months,
which was then tapered off.
To date, she has had no further episodes of microangiopathy and
remains healthy.
4. Conclusion
Congenital TTP is uncommon condition which presents with
MAHA, thrombocytopenia and severely low levels of ADAMTS13.
Plasma exchange and high dose corticosteroids are the recommended treatment options. Peripheral blood ﬁlm examination is
mandatory for FRBCs.
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